ALC Latest Headlines

Alcon (ALC) Receives a Hold from Barclays

at www.tipranks.com (Fri, 27-Feb 2:25 AM)

This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

at www.benzinga.com (Thu, 26-Feb 1:37 PM)

Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN), Mirum Pharmaceuticals (MIRM) and Alcon (ALC)

at www.tipranks.com (Thu, 26-Feb 8:30 AM)

Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC)

at www.tipranks.com (Thu, 26-Feb 5:50 AM)

Alcon Accelerates Growth with Strong Q4 2025 Results and Positive 2026 Outlook Driven by Product Innovation

Market Chameleon (Wed, 25-Feb 7:08 AM)

Alcon targets 5%–7% sales growth in 2026 while expanding Unity platform and launching new IOLs

at seekingalpha.com (Wed, 25-Feb 1:38 PM)

Alcon (ALC) Receives a Sell from Bank of America Securities

at www.tipranks.com (Wed, 25-Feb 7:38 AM)

Alcon (ALC): Solid Fundamentals and Market Recovery Support Buy Rating

at www.tipranks.com (Wed, 25-Feb 1:45 AM)

Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion

at www.tipranks.com (Tue, 24-Feb 6:06 PM)

Alcon slips as Q4 financial results miss on both lines

at seekingalpha.com (Tue, 24-Feb 5:45 PM)

Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation

at www.tipranks.com (Tue, 24-Feb 5:01 PM)

Alcon Non-GAAP EPS of $0.78 misses by $0.01, revenue of $2.7B misses by $10M

at seekingalpha.com (Tue, 24-Feb 4:32 PM)

Alcon Completes $750 Million Share Buyback—1.9% of Shares Repurchased to Offset Incentive Plan Dilution

Market Chameleon (Wed, 21-Jan 7:11 AM)